Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Forward Ventures is a prominent life-science venture capital firm founded in 1990 and headquartered in San Diego, California. With over $450 million in assets under management, the firm has established itself as a key player in the biotech and healthcare sectors. Over the years, Forward Ventures has successfully invested in more than 60 companies through five distinct funds, showcasing its commitment to fostering innovation in biopharmaceutical therapeutics. The firm is recognized for its strategic approach to investing, focusing on companies that are dedicated to developing and commercializing groundbreaking therapies aimed at addressing unmet medical needs. This long-standing presence in the industry has allowed Forward Ventures to build a robust network and reputation, making it a sought-after partner for startups in the life sciences space.
Forward Ventures maintains a comprehensive investment focus that spans all stages of company development, from Friends and Family rounds to Growth Equity. The firm primarily concentrates on biopharmaceutical therapeutics, seeking to support companies that are pioneering innovative therapies to meet significant medical needs. This includes investments in early-stage ventures, such as angel and seed funding, as well as later-stage investments in Series A, B, and C rounds. By engaging with companies at various stages, Forward Ventures aims to provide the necessary capital and strategic guidance to help these businesses thrive in a competitive landscape. The firm’s geographic focus is primarily on North America, allowing it to leverage local market insights and foster close relationships with portfolio companies. Forward Ventures looks for visionary founders and teams that are committed to making a meaningful impact in the healthcare sector.
Forward Ventures boasts a diverse portfolio of over 60 companies, primarily within the biotech and healthcare sectors. The firm has a proven track record of supporting innovative startups that are at the forefront of developing biopharmaceutical therapeutics. While specific company names and outcomes are not detailed in the provided information, the breadth of their portfolio reflects a commitment to investing in ventures that address critical healthcare challenges. By backing companies across various stages of development, Forward Ventures has positioned itself as a vital partner in the life sciences ecosystem, contributing to advancements that have the potential to transform patient care and treatment options.
Forward Ventures invests across all stages of company development, including Friends and Family, Angel, Pre Seed, Seed, Seed Plus, Series A, Series B, Series C, and Growth Equity. This broad approach allows them to support companies at various points in their growth journey.
The firm primarily focuses on the biotech and healthcare sectors, with a specific emphasis on biopharmaceutical therapeutics. They seek to invest in companies that are developing innovative therapies for unmet medical needs.
Forward Ventures has a geographic focus on North America, which enables them to leverage local market insights and build strong relationships with their portfolio companies.
While specific check sizes are not detailed, Forward Ventures invests across a range of stages, suggesting that their check sizes vary depending on the stage of the company and the specific funding needs.
For pitching to Forward Ventures, it is advisable to present a clear and compelling business case that highlights the innovative aspects of your therapy and its potential to address unmet medical needs. Specific details about their pitch process were not provided, so reaching out directly for guidance may be beneficial.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.